1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 20 JULY 2015

Key Pharma News 20 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 30 pages

Industry Trend Analysis - Horizon Will Need To Raise Offer For Depomed
Industry Brief - Allergan To Acquire Worldwide Rights To Merck's CGRP Migraine Development Programme
Industry Brief - Lilly/SDP Sign Sales Collaboration Agreement For Trulicity In Japan
Industry Trend Analysis - J&J To Remain Committed To HCV
Industry Brief - Biogen Plans New Production Plant In Switzerland
Industry Brief - Baxalta Launched To Deliver Therapies For Orphan Diseases And Underserved Conditions
Industry Trend Analysis - Receptos Acquisition Will Enhance Celgene's Blockbuster Autoimmune Expectations
Industry Brief - Sanofi To Reorganise Business Structure
Industry Trend Analysis - Newly Approved Rexulti Will Need To Be Differentiated From Predecessor Abilify
Industry Trend Analysis - Cobimetinib/Zelboraf Combination Will Gain Delayed FDA Approval
Industry Brief - FDA Approves Novartis' New Heart Failure Medicine Entresto
Industry Brief - Spiolto Respimat Approved In First European Countries
Industry Brief - FDA Approves Orkambi For CF
Industry Brief - EC Approves Vanda's Hetlioz For Non-24
Industry Brief - Sanofi's Lantus XR Approved In Japan
Industry Brief - EU Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLL
Industry Trend Analysis - FDA's Expectations Indicate A Rapidly-Emerging Biosimilar Market Ahead
Industry Brief - Imbruvica Gains EU Approval For WM
Industry Trend Analysis - Necitumumab Closes In On Approval
Industry Brief - Mylan Launches Bexarotene In US
Industry Trend Analysis - Path Opened For Chinese Generic Sofosbuvir But Impact On Gilead Will Be Muted
Industry Trend Analysis - Iressa's US Return Will Be Further Enhanced By Liquid Biopsy
Industry Trend Analysis - Actavis' Grip On Namenda Market To Diminish
Industry Trend Analysis - EMA's HPV Vaccine Safety Review Will Have Little Impact On Sales
Industry Brief - Teva Launches Almotriptan In US
Industry Trend Analysis - Remsima On Course To Be A Global Biosimilar
Industry Trend Analysis - Ixazomib Will Gain Swift Approval In US
Industry Brief - Hospira Gains Bivalirudin Approval; TMC Enters Authorised Generic Agreement With Sandoz
Industry Trend Analysis - Big Pharma Investment In Alzheimer's To Continue Despite Sembragiline's Failure
Industry Trend Analysis - Oncolytics Biotech Will Be Target For Immunotherapy Partnerships
Industry Trend Analysis - Array's BRAF Inhibitor Success Relies On Differentiation
Industry Brief - Novo Nordisk Successfully Completes First Phase IIIa Trial With Semaglutide
Industry Brief - Phase III Results Show LDL-C Reductions Of More Than 60% In Praluent-Treated Japanese Patients
Industry Trend Analysis - Atezolizumab Will Be Significant Anti-PD-1 Competitor In 2016

Table Of Contents

Key Pharma News 20 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.